| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34485477 |
| PharmacoGx | BRD-K34485477 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF396 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | B3GNT5 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.07 |
| mRNA | OR4K13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | ESD | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | NLRP5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | NUDT15 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | AC009014.3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | DYDC1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | SLC16A6 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | HADHB | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
